AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27013313 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation of breastfeeding at ≤1 hour
Number of subjects: 99632
Study 27013313 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation of breastfeeding at 2-23 hours
Number of subjects: 99632
Study 27013313 — intervention group
Group type: EXPERIMENTAL
Intervention: Initiation of breastfeeding at 24-96 hours
Number of subjects: 99632
Study 27013313 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding at 1 month
Number of subjects: 99632
Study 24678761 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention programme comprising three structured and individualised counselling sessions on a healthy diet, regular physical activity, and weight monitoring during pregnancy and one session after delivery.
Number of subjects: 2500
Study 24678761 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention programme
Number of subjects: 2500
Study 24678761 — intervention group
Group type: COMPARATOR
Intervention: General recommendations for a healthy lifestyle (Control)
Number of subjects: 2500
Study 24345027 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention to reduce sodium intake
Number of subjects: 240
Study 21038947 — intervention group
Group type: EXPERIMENTAL
Intervention: Worry
Number of subjects: 73
Study 21038947 — intervention group
Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 73
Study 21038947 — intervention group
Group type: COMPARATOR
Intervention: Neutral thought activity
Number of subjects: 73
Study 18412719 — intervention group
Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD)
Number of subjects: 35
Study 18412719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 17061750 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary soy supplement
Number of subjects: 705
Study 17061750 — intervention group
Group type: COMPARATOR
Intervention: Direct mailings
Number of subjects: 705
Study 17061750 — intervention group
Group type: COMPARATOR
Intervention: Newspaper advertisements
Number of subjects: 705
Study 17061750 — intervention group
Group type: COMPARATOR
Intervention: Radio advertisements
Number of subjects: 705
Study 12822844 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy massage
Number of subjects: 0
Study 12822844 — intervention group
Group type: COMPARATOR
Intervention: Relaxation therapy
Number of subjects: 0
Study 12822844 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 0
Study 11205485 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (ad libitum diet low in animal fat and refined carbohydrates, rich in low-glycemic-index foods, monounsaturated and n-3 polyunsaturated fatty acids, and phytoestrogens) with intensive dietary counseling and specially prepared group meals twice a week over 4.5 months.
Number of subjects: 104
Study 11205485 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary intervention)
Number of subjects: 104
Study 11205485 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 104
Study 11205485 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study 9755359 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 30
Study 9755359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 7722994 — intervention group
Group type: EXPERIMENTAL
Intervention: Validated and improved alcoholism treatment methods from Project MATCH and other studies
Number of subjects: 0
Study 7722994 — intervention group
Group type: EXPERIMENTAL
Intervention: Researcher-provider interactions
Number of subjects: 0
Study 7722994 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective communication between providers and researchers
Number of subjects: 0
Study 7722994 — intervention group
Group type: EXPERIMENTAL
Intervention: Research in organizational, management and delivery mechanisms
Number of subjects: 0
Study 3397890 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative quantitative keratometry with controlled intraocular pressure at standard physiologic level
Number of subjects: 0
Study 3397890 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative quantitative keratometry without controlled intraocular pressure
Number of subjects: 0
Study 29777952 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance group - participants believed they could avoid full exposure to a painful heat stimulus by pressing the stop button.
Number of subjects: 64
Study 29777952 — intervention group
Group type: COMPARATOR
Intervention: Control group - participants believed they were exposed to the full painful heat stimulus at all times.
Number of subjects: 64
Study 28086983 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-sampling delivered by mail
Number of subjects: 600
Study 28086983 — intervention group
Group type: COMPARATOR
Intervention: HPV self-sampling delivered by CHW
Number of subjects: 600
Study 25722291 — intervention group
Group type: EXPERIMENTAL
Intervention: CC‐H5N1 vaccine (3.75 µg of hemagglutinin antigen with AS03 adjuvant)
Number of subjects: 521
Study 25722291 — intervention group
Group type: EXPERIMENTAL
Intervention: CC‐H5N1 vaccine (1.9 µg of hemagglutinin antigen with AS03 adjuvant)
Number of subjects: 521
Study 25722291 — intervention group
Group type: COMPARATOR
Intervention: Embryonated-egg-derived vaccine (3.75 µg of HA with AS03)
Number of subjects: 521
Study 25722291 — intervention group
Group type: COMPARATOR
Intervention: Embryonated-egg-derived vaccine (15 µg of plain HA)
Number of subjects: 521
Study 25722291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 521
Study 24049441 — intervention group
Group type: EXPERIMENTAL
Intervention: Online breathing program with animated diagram and video-guided instruction
Number of subjects: 60
Study 24049441 — intervention group
Group type: COMPARATOR
Intervention: Conventional patient education on discharge from hospital
Number of subjects: 60
Study 20872150 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 18
Study 19016202 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous moxifloxacin plus intravitreal 1 mg Vancomycin plus 2.25 mg Ceftazidim
Number of subjects: 0
Study 19016202 — intervention group
Group type: COMPARATOR
Intervention: Intravenous moxifloxacin only
Number of subjects: 0
Study 17147049 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term lithium treatment
Number of subjects: 51
Study 17147049 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 51
Study 12568412 — intervention group
Group type: EXPERIMENTAL
Intervention: Cal+D-group (1200 mg calcium plus 800 IU cholecalciferol)
Number of subjects: 122
Study 12568412 — intervention group
Group type: COMPARATOR
Intervention: Cal-group (1200 mg calcium)
Number of subjects: 122
Study 12568412 — intervention group
Group type: EXPERIMENTAL
Intervention: Cal+D-group
Number of subjects: 122
Study 10738705 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dust exposure (2.4 mg/m3)
Number of subjects: 257
Study 10738705 — intervention group
Group type: EXPERIMENTAL
Intervention: Respirable dust exposure (0.16 mg/m3)
Number of subjects: 257
Study 10738705 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotoxin exposure (614 EU/m3)
Number of subjects: 257
Study 10738705 — intervention group
Group type: EXPERIMENTAL
Intervention: Ammonia exposure (12 ppm)
Number of subjects: 257
Study 8707128 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (50 micrograms)
Number of subjects: 0
Study 8707128 — intervention group
Group type: COMPARATOR
Intervention: Octreotide untreated
Number of subjects: 0
Study 1405327 — intervention group
Group type: EXPERIMENTAL
Intervention: ANF (5 pmol/kg/min) with prazosin (0.25 mg)
Number of subjects: 8
Study 1405327 — intervention group
Group type: COMPARATOR
Intervention: ANF (5 pmol/kg/min)
Number of subjects: 8
Study 1405327 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin (0.25 mg)
Number of subjects: 8
Study 30570511 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel Strength Training (FST)
Number of subjects: 29
Study 30570511 — intervention group
Group type: COMPARATOR
Intervention: High-Intensity Training (HIT)
Number of subjects: 29
Study 30570511 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Training (LIT)
Number of subjects: 29
Study 30570511 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 29
Study 29133954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ghrelin (3 mcg kg−1 loading dose followed by 16.9 ng/kg/min infusion)
Number of subjects: 0
Study 29133954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ghrelin
Number of subjects: 0
Study 27196032 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejaculatory abstinence (EA) for 1 day
Number of subjects: 0
Study 27196032 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejaculatory abstinence (EA) for 2 days
Number of subjects: 0
Study 27196032 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejaculatory abstinence (EA) for 2-7 days (recommended by WHO)
Number of subjects: 0
Study 27196032 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejaculatory abstinence (EA) for 9-11 days (long)
Number of subjects: 0
Study 24443845 — intervention group
Group type: EXPERIMENTAL
Intervention: Football Fans in Training (FFIT) programme
Number of subjects: 747
Study 21416634 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcarnosine 1% lubricant eye drops
Number of subjects: 0
Study 21144850 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole (20 mg/day) + Clopidogrel (75 mg/day)
Number of subjects: 165
Study 21144850 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel alone (75 mg/day)
Number of subjects: 165
Study 17485133 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based regimens
Number of subjects: 6906
Study 17485133 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-based regimens
Number of subjects: 6906
Study 16118073 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise training (80% of VO2peak)
Number of subjects: 16
Study 16118073 — intervention group
Group type: COMPARATOR
Intervention: Low intensity exercise training (60% of VO2peak)
Number of subjects: 16
Study 16118073 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study 11896780 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid adhesive bandage (LAB)
Number of subjects: 162
Study 11896780 — intervention group
Group type: COMPARATOR
Intervention: Control device (Band‐Aid brand adhesive bandage)
Number of subjects: 162
Study 10193878 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight loss intervention in 10 men and 10 women
Number of subjects: 100
Study 10193878 — intervention group
Group type: COMPARATOR
Intervention: Comparison of EE and FM between genders
Number of subjects: 100
Study 7753330 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin (ST)
Number of subjects: 10
Study 7753330 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 10
Study 1688983 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50-100 mg/day)
Number of subjects: 17
Study 1688983 — intervention group
Group type: COMPARATOR
Intervention: Verapamil (160-240 mg/day)
Number of subjects: 17
Study 7027178 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir (ACV) 3% ointment
Number of subjects: 52
Study 7027178 — intervention group
Group type: COMPARATOR
Intervention: Idoxuridine (IDU) 0.5% ointment
Number of subjects: 52
Study 31228190 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 46297
Study 31228190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46297
Study 28070653 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine infusion at 0.5 µg/kg/min during induction of anesthesia
Number of subjects: 29
Study 28070653 — intervention group
Group type: COMPARATOR
Intervention: Control group (no phenylephrine infusion)
Number of subjects: 29
Study 25689090 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based parenting program
Number of subjects: 307
Study 22922525 — intervention group
Group type: EXPERIMENTAL
Intervention: Reward condition (risk-averse mental set)
Number of subjects: 27
Study 22922525 — intervention group
Group type: COMPARATOR
Intervention: Standard condition (risk-seeking mental set)
Number of subjects: 27
Study 22922525 — intervention group
Group type: EXPERIMENTAL
Intervention: Stop error trials in Conservatives
Number of subjects: 27
Study 22922525 — intervention group
Group type: COMPARATOR
Intervention: Stop success trials in Riskys
Number of subjects: 27
Study 21992003 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol/amlodipine 50/5
Number of subjects: 402
Study 21992003 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol/amlodipine 25/2.5
Number of subjects: 402
Study 21992003 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol 50 mg
Number of subjects: 402
Study 21992003 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol 25 mg
Number of subjects: 402
Study 21992003 — intervention group
Group type: EXPERIMENTAL
Intervention: amlodipine 5 mg
Number of subjects: 402
Study 19229839 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (DLX)
Number of subjects: 17
Study 17274213 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM)
Number of subjects: 23
Study 17274213 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 23
Study 15225891 — intervention group
Group type: EXPERIMENTAL
Intervention: 50mg per day naltrexone
Number of subjects: 66
Study 15225891 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5mg per day naltrexone
Number of subjects: 66
Study 15225891 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05mg per day naltrexone
Number of subjects: 66
Study 11700403 — intervention group
Group type: EXPERIMENTAL
Intervention: Assist Control/Volume-Targeted (AC/VT)
Number of subjects: 8
Study 11700403 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Support
Number of subjects: 8
Study 11700403 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous Breathing
Number of subjects: 8
Study 9207606 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 70
Study 9207606 — intervention group
Group type: COMPARATOR
Intervention: IVF
Number of subjects: 70
Study 8250304 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin ointment
Number of subjects: 60
Study 8250304 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 60
Study 3311661 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg cisapride
Number of subjects: 12
Study 3311661 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg cisapride
Number of subjects: 12
Study 3311661 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg cisapride administered tid for three days
Number of subjects: 12
Study 3311661 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg cisapride administered tid for three days
Number of subjects: 12
Study 3311661 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31738117 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0
Study 31738117 — intervention group
Group type: COMPARATOR
Intervention: Platinum-based chemotherapy
Number of subjects: 0
Study 26756988 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-administered questionnaires (SRS-30 and PODCI)
Number of subjects: 96
Study 26756988 — intervention group
Group type: COMPARATOR
Intervention: Pen and paper-administered questionnaires (SRS-30 and PODCI)
Number of subjects: 96
Study 26756988 — intervention group
Group type: COMPARATOR
Intervention: Paper-administered questionnaires (SRS-30 and PODCI)
Number of subjects: 96
Study 25485463 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoting Alternative Thinking Strategies (PATHS)
Number of subjects: 705
Study 25485463 — intervention group
Group type: COMPARATOR
Intervention: Control curriculum with few SEL topics
Number of subjects: 705
Study 23279412 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based local anaesthesia teaching (Group II)
Number of subjects: 20
Study 23279412 — intervention group
Group type: COMPARATOR
Intervention: Traditional classroom lecture format (Group I)
Number of subjects: 20
Study 21366030 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage with prescribed laxatives
Number of subjects: 60
Study 21366030 — intervention group
Group type: COMPARATOR
Intervention: Prescribed laxatives only
Number of subjects: 60
Study 18651540 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate 2 mg every 4 weeks for 48 weeks
Number of subjects: 16
Study 16466180 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 15113492 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health Link programme
Number of subjects: 335
Study 15113492 — intervention group
Group type: COMPARATOR
Intervention: Control group (service development as usual)
Number of subjects: 335
Study 11590392 — intervention group
Group type: EXPERIMENTAL
Intervention: Worker education and voluntary medical surveillance introduced in 1994
Number of subjects: 8000
Study 11590392 — intervention group
Group type: EXPERIMENTAL
Intervention: Change to low-protein, powder-free NRL gloves in 1995
Number of subjects: 8000
Study 11590392 — intervention group
Group type: EXPERIMENTAL
Intervention: Change to lower protein, powder-free NRL sterile gloves in 1997
Number of subjects: 8000
Study 9031453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofibrate
Number of subjects: 99
Study 9031453 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 99
Study 8340158 — intervention group
Group type: EXPERIMENTAL
Intervention: SCH 42495
Number of subjects: 2
Study 8340158 — intervention group
Group type: EXPERIMENTAL
Intervention: UK 79300
Number of subjects: 2
Study 8340158 — intervention group
Group type: COMPARATOR
Intervention: Recumbent posture
Number of subjects: 2
Study 8340158 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin II infusion
Number of subjects: 2
Study 3440612 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-MDP bone scintigraphy performed at 6 weeks, 3, 6, and 12 months after internal fixation.
Number of subjects: 35
Study 3440612 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-MDP bone scintigraphy
Number of subjects: 35
Study 30880627 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-body repeated-sprint training in hypoxia (RSH, simulated altitude 3000 m, n=18)
Number of subjects: 36
Study 30880627 — intervention group
Group type: COMPARATOR
Intervention: Upper-body repeated-sprint training in normoxia (RSN, 300 m, n=18)
Number of subjects: 36
Study 30880627 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper-body repeated-sprint training in hypoxia (RSH)
Number of subjects: 36
Study 30880627 — intervention group
Group type: COMPARATOR
Intervention: Upper-body repeated-sprint training in normoxia (RSN)
Number of subjects: 36
Study 27663079 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 676
Study 27663079 — intervention group
Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 676
Study 25825948 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss diets differing in fat, protein, and carbohydrates
Number of subjects: 424
Study 23492248 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention with one face-to-face session, pedometer use, and seven telephone calls
Number of subjects: 92
Study 23492248 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention
Number of subjects: 92
Study 23492248 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 21658510 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-order driving skill training
Number of subjects: 36
Study 21658510 — intervention group
Group type: EXPERIMENTAL
Intervention: Vehicle handling skill training
Number of subjects: 36
Study 21658510 — intervention group
Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 36
Study 19608831 — intervention group
Group type: EXPERIMENTAL
Intervention: Total IV anesthetic (TIVA) technique using propofol and remifentanil
Number of subjects: 0
Study 19608831 — intervention group
Group type: COMPARATOR
Intervention: Inhaled anesthetic technique using desflurane (DES)
Number of subjects: 0
Study 19608831 — intervention group
Group type: EXPERIMENTAL
Intervention: FNEMG monitoring
Number of subjects: 0
Study 19608831 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 0
Study 17530052 — intervention group
Group type: EXPERIMENTAL
Intervention: 18% hydrochloric acid
Number of subjects: 30
Study 17530052 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide
Number of subjects: 30
Study 17530052 — intervention group
Group type: COMPARATOR
Intervention: 10% carbamide peroxide
Number of subjects: 30
Study 15476159 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-dose recombinant HBV vaccination
Number of subjects: 318
Study 15476159 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dose recombinant HBV vaccination
Number of subjects: 318
Study 15476159 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-dose plasma-derived HBV vaccination
Number of subjects: 318
Study 15476159 — intervention group
Group type: COMPARATOR
Intervention: 3-dose regimens (both recombinant and plasma-derived)
Number of subjects: 318
Study 11448901 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide (low-dose arm, 200 mg/day)
Number of subjects: 63
Study 11448901 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide (high-dose arm, escalated from 200 mg/day to 1200 mg/day)
Number of subjects: 63
Study 11448901 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide (both arms)
Number of subjects: 63
Study 9706917 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOC‐201 (Study A: 6.9 mL/kg; Study B: 9.2 mL/kg)
Number of subjects: 24
Study 9706917 — intervention group
Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch
Number of subjects: 24
Study 7885687 — intervention group
Group type: EXPERIMENTAL
Intervention: Aciclovir (Zovirax)
Number of subjects: 51
Study 7885687 — intervention group
Group type: EXPERIMENTAL
Intervention: Epervudine (Hevizos)
Number of subjects: 51
Study 2679035 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine at an initial rate of 3 micrograms/kg/min
Number of subjects: 120